COX-2 Expression in Cervical Cancer
Author Information
Author(s): Ferrandina G, Lauriola L, Zannoni G F, Distefano M G, Legge F, Salutari V, Gessi M, Maggiano N, Scambia G, Ranelletti F O
Primary Institution: Catholic University of the Sacred Heart
Hypothesis
This study aims at investigating the relationship between cyclooxygenase-2 expression in tumour vs stroma inflammatory compartment and its possible clinical role.
Conclusion
The study showed that assessing COX-2 status in both tumour and stroma compartments can help identify cervical cancer patients with poor chances of treatment response and unfavorable prognosis.
Supporting Evidence
- High COX-2 expression in tumour cells is associated with poor treatment response.
- Patients with a high tumour/stroma COX-2 IDV ratio had a shorter overall survival rate.
- COX-2 status in stroma inflammatory cells is associated with better clinical outcomes.
Takeaway
This study looked at a protein called COX-2 in cervical cancer and found that how much of it is in the tumor compared to the surrounding tissue can help doctors understand how well a patient might respond to treatment.
Methodology
Immunostaining of tumour tissue sections was performed with antibodies against COX-2 and other markers to characterize stroma inflammatory cells in cervical tumours.
Participant Demographics
Median age was 51 years (range 24–76); included stage IB-IV cervical cancer patients.
Statistical Information
P-Value
P<0.0001
Confidence Interval
95% CI 35–71
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website